Christian Angermayer is a German entrepreneur and investor hails in England. He is known for his involvement in fintech, Internet & Technology (from e-commerce to deep tech), Life Sciences, Media & Entertainment, Real Estate and Natural Resources. ^[3][2][3] He is a partner at Limestone Capital as well as the owner of his family office, the Apeiron Investment Group. ^[13]

While a student in college at the age of 19 years old, he started a biotech company in 1999 that eventually became Alnylam.

He quit school to work on the biotech.

Now the company has a market cap of about $12 billion and has submitted its first drug, patisiran, for FDA approval.

^[9]

In 2012, Angermayer founded the Apeiron Investment Group, his family office and merchant banking business.

Through the Apeiron Investment Group, Angermayer focuses on investments in Germany and Africa on Financial Services, Internet and Technology, Life Sciences, Media, Real Estate and Natural Resources.

Angermayer is involved in a wide variety of deals ranging from seed/start up investments to large scale restructuring of major companies.

The Apeiron Investment Group has approximately 1 billion euros under management.

^[13]

In July 2020, Angermayer received €13m for brokering SoftBank’s controversial $1.1bn investment in Wirecard. He was paid by both sides in an intricate deal, where the reputation of the SoftBank as the world’s biggest tech investor helped to deflect allegations of accounting fraud at Wirecard while generating large profits for SoftBank Corp. executives.

Wirecard collapsed in June 2020, owing at least €3.2bn to banks and investors, including €900m ($1.1bn) of convertible bond debt issued to SoftBank Corp. and then sold on to outside investors in September 2019 in a deal structured by Credit Suisse. The following month Wirecard paid Angermayer a €11.25m "success fee", equivalent to 1.25 percent of the €900m raised. SoftBank Investment Advisers, which manages the group's $100bn Vision Fund, also paid Angermayer around €2m for his role as middleman.^[23]

The agreement with Wirecard detailing the success fee for Angermayer's firm, Apeiron Advisory, was dated April 20, 2019.

Days later the group announced SoftBank's investment, alongside a "strategic co-operation agreement".^[23]

Besides his investment firm, he has merged his profound experience at the nexus of traditional financial services and technology.

He is considered one of the most active and significant investors in European fintech companies with a special focus on cryptocurrencies and blockchain-related business models.

^[11]

Apeiron's cryptocurrency investments are mainly done via its subsidiary CRYPTOLOGY PLC.

Other cutting-edge areas for investments Christian is currently most excited about are longevity and anti-aging technologies, aerospace technologies, artificial intelligence and new drugs for mental well-being and enhancement.

^[11]

Angermayer was born and raised in Germany. He currently lives in London. ^[11]